Tobias WhelanResearch Associate
Focuses on the design of both preclinical and clinical studies within the clinical development programme.
Prior to his role as a Finance Executive and before joining COMPASS Pathways, Tobias completed his MSci in Neuroscience at the University of Southampton. His research projects involved the investigation of autism spectrum disorder in addition to novel therapeutic interventions in mental health. During his thesis, Tobias used genetic engineering techniques to study the role of an autism-associated gene on behaviour.
COMPASS provides the opportunity for innovation within a collaborative environment, driving improved treatment options for disorders of considerable unmet need with a patient-centric approach.